July 18, 2012 – Next week, a federal panel will decide the fate of lawsuits filed by victims who took Pradaxa and suffered internal bleeding injuries. The decision will affect whether the cases will be consolidated under one court, and where that court will be located.
Any patient who suffered internal bleeding or lost a loved one after taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.
Pradaxa is an anticoagulant prescribed to those afflicted with atrial fibrillation in order to prevent strokes and blood clots. It has only been on the market since October of 2010, however, for the year ending in February, 2012, the drug sold over $1 billion with prescriptions to hundreds of thousands of patients.
The FDA issued a warning on December 7, 2011 that it would launch an investigation into the safety of Pradaxa after the agency received more injury and death reports on the drug than expected. The Institute for Safe Medication Practices also recently stated that Pradaxa had more reports of bleeding or death to the FDA in 2011 than all other medications.
Drug injury lawyers expect thousands of lawsuits over Pradaxa bleeding injury or death. Therefore, they have filed a motion requesting that all cases be moved to one central federal court. The United States Judicial Panel on Multidistrict Litigation (JPML) has stated they will decide whether the cases are to be consolidated, and where, on July 26, 2012.
Moving all Pradaxa lawsuits into one federal court will benefit victims more than a Pradaxa class action lawsuit since it will expedite the litigation process and help them share valuable evidence while still having separate lawsuits. However, due to the specialized nature of these federal MDL cases, only certain lawyers can adequately help with a case.
Anyone affected by Pradaxa side effects is urged to speak with a lawyer about their legal options. The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.
Contact us today for more information on the research, warnings, side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer.